Analysing data from patient medical records to investigate whether a 18FDG-PET scan can predict survival in patients with breast cancer that can be treated with surgery
Not Applicable
Completed
- Conditions
- Operable breast cancer.Cancer
- Registration Number
- ISRCTN17962845
- Lead Sponsor
- niversitair Ziekenhuis Brussel
- Brief Summary
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35582655/ (added 14/06/2023) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33689151/ (added 14/06/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 182
Inclusion Criteria
1. Patients treated at the UZ Brussel
2. Diagnosed in the period 2002-2015
3. Primary breast cancer
4. Histologically confirmed
5. Operable
6. Pre-treatment FDG-PET or PET/CT
Exclusion Criteria
1. Previous history of cancer
2. Primary sarcoma of the breast
3. Palliative surgery for symptom control
4. No histopathological confirmation of cancer
5. Noninvasive carcinoma
6. Metastatic disease demonstrated by imaging modes other than FDG-PET
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method